Increase: seen in gastric cancer, duodenal ulcer, gastric ulcer
Decrease: atrophic gastritis, gastric cancer
Increase: seen in gastric fundus gland atrophy, intestinal metaplasia or pseudopyloric gland metaplasia, heterogeneous hyperplasia, etc.
The progressive decrease in PG I/II ratio is associated with the progression of gastric mucosal atrophy.
Judge the gastric secretory function
Reflect the stomach acid
Suggest the location, degree and risk of gastric mucosal atrophy
Guide the rational use of drugs, such as proton pump preparations (PPI), non-steroidal anti-inflammatory drugs (NSAID), etc.